Uremic Toxin-Producing Bacteroides Species Prevail in the Gut Microbiota of Taiwanese CKD Patients: An Analysis Using the New Taiwan Microbiome Baseline

Author:

Shivani Subhashree,Kao Cheng-Yen,Chattopadhyay Amrita,Chen Jenn-Wei,Lai Liang-Chuan,Lin Wei-Hung,Lu Tzu-Pin,Huang I-Hsiu,Tsai Mong-Hsun,Teng Ching-Hao,Wu Jiunn-Jong,Hsieh Yi-Hsien,Wang Ming-Cheng,Chuang Eric Y.

Abstract

Rationale and ObjectiveGut microbiota have been targeted by alternative therapies for non-communicable diseases. We examined the gut microbiota of a healthy Taiwanese population, identified various bacterial drivers in different demographics, and compared them with dialysis patients to associate kidney disease progression with changes in gut microbiota.Study DesignThis was a cross-sectional cohort study.Settings and ParticipantsFecal samples were obtained from 119 healthy Taiwanese volunteers, and 16S rRNA sequencing was done on the V3-V4 regions to identify the bacterial enterotypes. Twenty-six samples from the above cohort were compared with fecal samples from 22 peritoneal dialysis and 16 hemodialysis patients to identify species-level bacterial biomarkers in the dysbiotic gut of chronic kidney disease (CKD) patients.ResultsSpecific bacterial species were identified pertaining to different demographics such as gender, age, BMI, physical activity, and sleeping habits. Dialysis patients had a significant difference in gut microbiome composition compared to healthy controls. The most abundant genus identified in CKD patients was Bacteroides, and at the species level hemodialysis patients showed significant abundance in B. ovatus, B. caccae, B. uniformis, and peritoneal dialysis patients showed higher abundance in Blautia producta (p ≤ 0.05) than the control group. Pathways pertaining to the production of uremic toxins were enriched in CKD patients. The abundance of the bacterial species depended on the type of dialysis treatment.ConclusionThis study characterizes the healthy gut microbiome of a Taiwanese population in terms of various demographics. In a case-control examination, the results showed the alteration in gut microbiota in CKD patients corresponding to different dialysis treatments. Also, this study identified the bacterial species abundant in CKD patients and their possible role in complicating the patients’ condition.

Funder

Ministry of Science and Technology

Yen Tjing Ling Medical Foundation

Publisher

Frontiers Media SA

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference63 articles.

1. Indoxyl Sulphate Promotes Aortic Calcification With Expression of Osteoblast-Specific Proteins in Hypertensive Rats;Adijiang;Nephrol. Dialysis Transplant.,2008

2. Cardiovascular Risk in Chronic Kidney Disease;Anavekar;Kidney Int. Supplement,2004

3. “295_Sørensen, Thorvald.Pdf”1948

4. Hepatic Microsomal Metabolism of Indole to Indoxyl, a Precursor of Indoxyl Sulfate;Banoglu;Eur. J. Drug Metab. Pharmacokinetics,2001

5. Sulfation of Indoxyl by Human and Rat Aryl (Phenol) Sulfotransferases to Form Indoxyl Sulfate;Banoglu;Eur. J. Drug Metab. Pharmacokinetics,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3